245 related articles for article (PubMed ID: 33205966)
1. Living Therapeutics: The Next Frontier of Precision Medicine.
Kelly VW; Liang BK; Sirk SJ
ACS Synth Biol; 2020 Dec; 9(12):3184-3201. PubMed ID: 33205966
[TBL] [Abstract][Full Text] [Related]
2. Engineering probiotics as living diagnostics and therapeutics for improving human health.
Zhou Z; Chen X; Sheng H; Shen X; Sun X; Yan Y; Wang J; Yuan Q
Microb Cell Fact; 2020 Mar; 19(1):56. PubMed ID: 32131831
[TBL] [Abstract][Full Text] [Related]
3. The potential impact of gut microbiota on your health:Current status and future challenges.
Sirisinha S
Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
[TBL] [Abstract][Full Text] [Related]
4. Microbiome systems biology advancements for natural well-being.
Chatterjee G; Negi S; Basu S; Faintuch J; O'Donovan A; Shukla P
Sci Total Environ; 2022 Sep; 838(Pt 2):155915. PubMed ID: 35568180
[TBL] [Abstract][Full Text] [Related]
5. Synthetic Biology Approaches to Engineer Probiotics and Members of the Human Microbiota for Biomedical Applications.
Bober JR; Beisel CL; Nair NU
Annu Rev Biomed Eng; 2018 Jun; 20():277-300. PubMed ID: 29528686
[TBL] [Abstract][Full Text] [Related]
6. Designer probiotics for the prevention and treatment of human diseases.
Chua KJ; Kwok WC; Aggarwal N; Sun T; Chang MW
Curr Opin Chem Biol; 2017 Oct; 40():8-16. PubMed ID: 28478369
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota in surgical and critically ill patients.
Ho KM; Kalgudi S; Corbett JM; Litton E
Anaesth Intensive Care; 2020 May; 48(3):179-195. PubMed ID: 32131606
[TBL] [Abstract][Full Text] [Related]
8. The sponge holobiont in a changing ocean: from microbes to ecosystems.
Pita L; Rix L; Slaby BM; Franke A; Hentschel U
Microbiome; 2018 Mar; 6(1):46. PubMed ID: 29523192
[TBL] [Abstract][Full Text] [Related]
9. Engineer probiotic bifidobacteria for food and biomedical applications - Current status and future prospective.
Zuo F; Chen S; Marcotte H
Biotechnol Adv; 2020 Dec; 45():107654. PubMed ID: 33159984
[TBL] [Abstract][Full Text] [Related]
10. Synthetic Biology Approaches in The Development of Engineered Therapeutic Microbes.
Kang M; Choe D; Kim K; Cho BK; Cho S
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228099
[TBL] [Abstract][Full Text] [Related]
11. Targeting friend and foe: Emerging therapeutics in the age of gut microbiome and disease.
Cho JA; Chinnapen DJF
J Microbiol; 2018 Mar; 56(3):183-188. PubMed ID: 29492875
[TBL] [Abstract][Full Text] [Related]
12. Microbial Medicine: Prebiotic and Probiotic Functional Foods to Target Obesity and Metabolic Syndrome.
Green M; Arora K; Prakash S
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326175
[TBL] [Abstract][Full Text] [Related]
13. Does the buck stop with the bugs?: an overview of microbial dysbiosis in rheumatoid arthritis.
Sandhya P; Danda D; Sharma D; Scaria V
Int J Rheum Dis; 2016 Jan; 19(1):8-20. PubMed ID: 26385261
[TBL] [Abstract][Full Text] [Related]
14. Microbial contributions to chronic inflammation and metabolic disease.
Shanahan F; Sheehan D
Curr Opin Clin Nutr Metab Care; 2016 Jul; 19(4):257-62. PubMed ID: 27097361
[TBL] [Abstract][Full Text] [Related]
15. Engineering commensal bacteria to rewire host-microbiome interactions.
Hwang IY; Chang MW
Curr Opin Biotechnol; 2020 Apr; 62():116-122. PubMed ID: 31654857
[TBL] [Abstract][Full Text] [Related]
16. Probiotic and synbiotic therapy in the critically ill: State of the art.
Davison JM; Wischmeyer PE
Nutrition; 2019 Mar; 59():29-36. PubMed ID: 30415160
[TBL] [Abstract][Full Text] [Related]
17. Understanding the host-microbe interactions using metabolic modeling.
Jansma J; El Aidy S
Microbiome; 2021 Jan; 9(1):16. PubMed ID: 33472685
[TBL] [Abstract][Full Text] [Related]
18. Gut Microbiome Dysbiosis and Immunometabolism: New Frontiers for Treatment of Metabolic Diseases.
Belizário JE; Faintuch J; Garay-Malpartida M
Mediators Inflamm; 2018; 2018():2037838. PubMed ID: 30622429
[TBL] [Abstract][Full Text] [Related]
19. Gene editing and genetic engineering approaches for advanced probiotics: A review.
Yadav R; Kumar V; Baweja M; Shukla P
Crit Rev Food Sci Nutr; 2018 Jul; 58(10):1735-1746. PubMed ID: 28071925
[TBL] [Abstract][Full Text] [Related]
20. Microbiome at the Frontier of Personalized Medicine.
Kashyap PC; Chia N; Nelson H; Segal E; Elinav E
Mayo Clin Proc; 2017 Dec; 92(12):1855-1864. PubMed ID: 29202942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
